Kaneh Bosm Biotechnology Inc Share Price Canadian Securities Exchange
Equities
CA4841902022
Drug Retailers
Sales 2018 | - | Sales 2019 | - | Capitalization | 13.23M 18.11M 1.1B |
---|---|---|---|---|---|
Net income 2018 | - 0 0 | Net income 2019 | -60M -82.13M -5B | EV / Sales 2018 * | - |
Net cash position 2018 * | - 0 0 | Net cash position 2019 * | - 0 0 | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15/19/15 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27/18/27 |
Corporate Officer/Principal | - | 25/19/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27/18/27 |
Matthew Fish
BRD | Director/Board Member | - | 29/19/29 |
1st Jan change | Capi. | |
---|---|---|
+14.46% | 3.03B | |
-3.40% | 1.44B | |
+51.37% | 528M | |
-12.27% | 441M | |
+43.19% | 183M | |
-5.29% | 90.78M | |
-33.41% | 72.26M | |
+40.45% | 56.21M |